Pfizer stock slips to EUR 26.72, down 1.84% premarket
Published on 11/04/2026 at 08:46 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSPfizer raises 2026 outlook
- Third-quarter revenue reached USD 16.6 billion as launched and acquired products gained momentum.
- Pfizer lifted its full-year revenue outlook to USD 62 billion to USD 64 billion and adjusted diluted EPS guidance to USD 2.95 to USD 3.05.
- Pipeline progress in oncology, obesity and vaccines remains a key focus for investors.
Pfizer stock traded at EUR 26.72 on Lang & Schwarz at 08:43 CET on Wednesday, November 4, 2026, 1.84% below the Xetra close of Tuesday, November 3, 2026 at EUR 27.22.
Pfizer's third-quarter performance gave investors a stronger outlook for the remainder of 2026. The company reported revenue of USD 16.6 billion and said products launched or acquired in recent years generated USD 3.8 billion in quarterly revenue, with operational growth of 32%.
Pfizer raised its full-year revenue forecast to USD 62 billion to USD 64 billion from USD 60.5 billion to USD 62.5 billion previously. Adjusted diluted earnings per share are now expected at USD 2.95 to USD 3.05, compared with the prior range of USD 2.80 to USD 3.00. The revised outlook was presented in Pfizer's third-quarter update.
Management also highlighted progress across the late-stage pipeline, including oncology, obesity and vaccines. Pfizer said it invested USD 8.3 billion in research and development during the first nine months of 2026 across its four therapeutic focus areas.
Investors will weigh the raised outlook against weaker demand for some COVID products and the continuing need to replace mature products with new launches and acquisitions. The earnings update therefore supports a more constructive near-term operating picture while leaving pipeline execution central to the longer-term case.
US equity markets provide the broader backdrop as investors assess pharmaceutical earnings and revised corporate outlooks.
For more context, see the more news and analyses on Pfizer stock. The real-time quote of Pfizer stock provides the latest trading view.
